ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Santhera Pharmaceuticals Holdings Ltd (PK)

Santhera Pharmaceuticals Holdings Ltd (PK) (SPHDF)

11.70
0.00
(0.00%)
마감 29 9월 5:00AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
11.70
매수가
11.70
매도가
11.70
거래량
-
0.00 일간 변동폭 0.00
9.40 52주 범위 13.35
market_cap
전일 종가
11.70
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
6,181,292
배당수익률
-
주가수익률
1.32
주당순이익(EPS)
8.86
매출
103.41M
순이익
54.78M

Santhera Pharmaceuticals Holdings Ltd (PK) 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Liestal, Che
설립됨
-
Santhera Pharmaceuticals Holdings Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker SPHDF. The last closing price for Santhera Pharmaceuticals (PK) was US$11.70. Over the last year, Santhera Pharmaceuticals (PK) shares have traded in a share price range of US$ 9.40 to US$ 13.35.

Santhera Pharmaceuticals (PK) currently has 6,181,292 shares in issue. The market capitalisation of Santhera Pharmaceuticals (PK) is US$72.32 million. Santhera Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 1.32.

SPHDF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10011.711.711.700CS
40011.711.711.700CS
120011.711.711.700CS
260011.711.711.700CS
522.324.46808510649.413.359.432611.18178889CS
156-4.1-25.949367088615.815.86.8221613.92727605CS
260-130.8-91.7894736842142.5142.56.8407931.9600281CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ZHCLFZenith Capital Corporation (CE)
US$ 0.10
(99,900.00%)
181.35k
EHVVFEhave Inc (CE)
US$ 0.0006
(59,900.00%)
15.71k
MCLDFmCloud Technologies Corporation (CE)
US$ 0.0002
(19,900.00%)
11.01k
NTRRNeutra Corporation (CE)
US$ 0.0002
(19,900.00%)
15.83M
SDCCQSmileDirectClub Inc (CE)
US$ 0.0002
(19,900.00%)
64.86k
JXMNFJaxon Mng Inc (PK)
US$ 0.000001
(-99.99%)
80k
SUNWQSunworks Inc (CE)
US$ 0.000001
(-99.50%)
634.2k
ONPHOncology Pharma Inc (CE)
US$ 0.000001
(-99.50%)
5.1k
RAHGFRoan Holdings Group Company Ltd (CE)
US$ 0.0002
(-99.43%)
1,000
SHOMSouthern Home Medical Inc (CE)
US$ 0.000001
(-99.00%)
400k
AURIAuri Inc New (PK)
US$ 0.00015
(50.00%)
557.32M
SPQSSportsQuest Inc (PK)
US$ 0.0004
(0.00%)
396.7M
DRNKNoHo Inc (PK)
US$ 0.0003
(0.00%)
324.38M
HMBLHUMBL Inc (PK)
US$ 0.0003
(0.00%)
216.25M
AAPJAAP Inc (PK)
US$ 0.0004
(100.00%)
203.21M

SPHDF Discussion

게시물 보기
Renee Renee 1 년 전
SPHDF one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
beebob77 beebob77 10 년 전
SPHDF is one step ahead in DMD submission!

Check out Santhera Pharm with a 100 - 400% opportunity:
In comparision to the peers PTC or SRPT we have a fair value of 180USD/share without NDA submission.

Expected Upcoming Milestones
Q4 2014 – Start Phase I CALLISTO study for omigapil in CMD.
H1 2015 – CHMP decision on Raxone as an LHON treatment.
H1 2015 – NDA and MAA submission for Raxone/Catena as a DMD treatment.
H1 2015 – NDA submission for Raxone/Catena for LHON.
H2 2015 – Commercial launch of Raxone for LHON in EU.
Q1 2016 – Commercial launch of Raxone/Catena for DMD in US and EU.
H1 2016 – Commercial launch of Raxone/Catena for LHON in US.


DMD - Market Opportunity
The various price points are, on average, between $300,000 and $500,000 per patient per year. If you consider this in terms of the target population, the company estimates there would be about 2,000 patients in the U.S. that would be amenable to Eteplirsen. This translates into a $600 million to $1 billion market opportunity in the U.S. alone. The EU could add 9,000 additional patients as well.

LifeSci Capital Coverage: link

ValualationLAB Analysis: link
👍️0
stocktrademan stocktrademan 10 년 전
$SPHDF recent news/filings

bullish

## source: finance.yahoo.com

Fri, 15 Aug 2014 05:15:00 GMT ~ Santhera Receives CHF 13.4 Million Through Sale of Treasury Shares

[GlobeNewswire] - LIESTAL, Switzerland -- Santhera Pharmaceuticals (SIX:SANN) today announced that it completed the sale of 200,000 registered shares of common stock at an average price of CHF 66.85 per share, a 4.3% premium ...

read full: http://finance.yahoo.com/news/santhera-receives-chf-13-4-051500317.html
*********************************************************


$SPHDF charts



basic chart ## source: eoddata.com



$SPHDF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SPHDF/company-info
Ticker: $SPHDF
OTC Market Place: OTC Pink Current
CIK code: not found
Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com
Incorporated In: Switzerland


$SPHDF share structure

## source: otcmarkets.com

Market Value: $255,314,992 a/o Aug 18, 2014
Shares Outstanding: 3,660,430 a/o Aug 29, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$SPHDF extra dd links

Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SPHDF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SPHDF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SPHDF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/news - http://finance.yahoo.com/q/h?s=SPHDF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SPHDF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SPHDF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SPHDF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Santhera+Pharmaceuticals+Holdings+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Santhera+Pharmaceuticals+Holdings+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Santhera+Pharmaceuticals+Holdings+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.santhera.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.santhera.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.santhera.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SPHDF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SPHDF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SPHDF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SPHDF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SPHDF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SPHDF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SPHDF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SPHDF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SPHDF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SPHDF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SPHDF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SPHDF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SPHDF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SPHDF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SPHDF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SPHDF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SPHDF



$SPHDF DD Notes ~ http://www.ddnotesmaker.com/SPHDF
👍️0